Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | BRD4 | O60885 | 13/20 | 0.43 |
| ▸ | BRD9 | Q9H8M2 | 1/20 | 0.39 |
| ▸ | BRD7 | Q9NPI1 | 1/20 | 0.39 |
| ▸ | MEN1 | O00255 | 2/20 | 0.35 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.35 |
| ▸ | LMNA | P02545 | 1/20 | 0.33 |
| ▸ | PABPC1 | P11940 | 1/20 | 0.32 |
| ▸ | APOBEC3A | P31941 | 1/20 | 0.32 |
| ▸ | EIF4H | Q15056 | 1/20 | 0.32 |
| ▸ | APOBEC3G | Q9HC16 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL19686146 | 0.86 | ESR1 (0.38) | BRD4MEN1KMT2ALMNA | |
| SCHEMBL19686085 | 0.84 | BRD4 (0.43) | BRD4BRD9BRD7MEN1KMT2A | |
| SCHEMBL19686084 | 0.83 | BRD4 (0.35) | BRD4BRD9BRD7 | |
| SCHEMBL19685867 | 0.83 | MEN1 (0.35) | BRD4MEN1KMT2ALMNAPABPC1 | |
| SCHEMBL19685872 | 0.81 | BRD4 (0.43) | BRD4BRD9BRD7MEN1KMT2A | |
| SCHEMBL19685859 | 0.79 | BRD4 (0.43) | BRD4BRD9BRD7MEN1KMT2A | |
| SCHEMBL19685860 | 0.79 | BRD4 (0.43) | BRD4BRD9BRD7MEN1KMT2A | |
| SCHEMBL19685730 | 0.79 | BRD4 (0.33) | BRD4BRD9BRD7 | |
| SCHEMBL19685734 | 0.76 | BRD4 (0.41) | BRD4BRD9BRD7MEN1KMT2A | |
| SCHEMBL19685946 | 0.76 | ALDH1A1 (0.42) | MEN1KMT2ALMNA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20170352817-A1 | POLYCYCLIC COMPOUND AND ORGANIC ELECTROLUMINESCENCE DEVICE INCLUDING THE SAME | KYUSHU UNIVERSITY, NATIONAL UNIVERSITY CORPORATION (JP) | 2017-12-07 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20170352817-A1 | POLYCYCLIC COMPOUND AND ORGANIC ELECTROLUMINESCENCE DEVICE INCLUDING THE SAME | CYC1, CCNA1, CYCS | BRD4 740/4885BRD9 1480/4885BRD7 2005/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.